The incidence of tuberculosis (TB) and especially multidrug-resistant TB 19 (MDR) and extreme drug resistance (XDR-TB) continue to increase 20 alarmingly worldwide and reliable and fast diagnosis of MDR-TB and 21 XDR-TB is essential for the adequate treatment of patients. So molecular 22 line probe assays (LPAs) for detection of MDR-TB and XDR-TB have 23 been endorsed by the World Health Organization (WHO). We analyzed 24 96 isolates from Beijing comparing culture-based drug susceptibility 25 testing (DST) to LPAs detecting rifampicin (RFP), isoniazid (INH), and 26 levofloxacin (LFX), amikacin (AM), capreomycin (CMP), ethambutol 27 (EMB) resistance. Compared to phenotypic DST, the GenoType 28
INTRODUCTION
In order to rapidly detect MDR-TB and XDR-TB, WHO The performance of GenoType MTBDRsl was also showed in Table   159 2.The sensitivity for detecting LFX resistance was 89.7% in fifteen isolates, and mutation was detected only at the wild type probes.
179
Of the fifteen isolates with mutation that detected only at wild type 180 probes, seven isolates had mutation atrpoBWT7, five isolates atWT8, two 181 isolates atWT3 and WT4 and one isolate at WT2 and WT3. According to 182 the kit manufacturer's recommendation, these isolates were considered 183 resistant and indicated the presence of a less common or rare mutation. detected using LPA in our study was C15T with loss of WT1, which 30. Ajbani K, Nikam C, Kazi M, Gray C, Boehme C, Balan K, Shetty WT, wild-type pattern with all respective bands visible; ΔWT, indicates lack of hybridization to the wild-type probe. MUT mutation.
